CLINICAL_TRIALS
trial_result
· 2025-07-01
Clinical Trial Update: Study to Evaluate Tezepelumab in Adults With Severe Uncontrolled Asthma [Phase 3]
Summary
A Phase 3 study evaluating tezepelumab in adults with severe uncontrolled asthma has completed, and its results were posted on 2025-07-01.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2025-07-01